Results 81 to 90 of about 8,373 (188)

Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the Ticlopidine Aspirin Stroke Study.

open access: yes, 1992
Ticlopidine has not been formally compared with aspirin in patients with a completed stroke. We therefore performed an analysis on a subgroup of patients from the Ticlopidine Aspirin Stroke Study (TASS) with a recent minor completed stroke as the ...
J W Harbison
core   +1 more source

Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP

open access: yesHaematologica, 1997
BACKGROUND AND OBJECTIVE: Antiplatelet agents are often included in plasma exchange-based regimens for thrombotic thrombocytopenic purpura (TTP) patients; however, the opportuneness of their use in TTP is still controversial.
E Bobbio-Pallavicini   +7 more
doaj  

Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia.

open access: yes, 1989
We compared combination therapy with low-dose aspirin plus ticlopidine to therapy with aspirin alone or ticlopidine alone in patients suffering transient ischemic attack or cerebral infarction. In 17, 24, and 23 patients, respectively, 300 mg/day aspirin,
I Kobayashi   +6 more
core   +1 more source

WI MINX PENAMBAI-(AN TICLOPIDINE PA'DA PENGELOLAAN INFARK MIOKARD AKUr (PANDANGAN TER7-64DAP RISIKO FERDARA1-64N) [PDF]

open access: yes, 1999
Background : The early administration of thrombolytic agents for salvaging the myocardiurn during acute myocardium infarction (AMI) is still the first choice in management of AMI patients.
halim, samsirun
core   +1 more source

Analysis of the structure of consumption of antiplatelet drugs in the Russian pharmaceutical market: 2014-2016

open access: yesКачественная клиническая практика, 2018
This article analyzes the volume of the Russian pharmaceutical market of antiplatelet drugs in the period 2014-2016. 80% of patients take clopidogrel generics, giving preference to Zilt®.
S. K. Zyryanov, E. V. Dumchenko
doaj  

Swelling of mitochondria by the platelet antiaggregating agent ticlopidine

open access: yes, 1986
Our studies on the effects of ticlopidine on mitochondrial functions led us to an intriguing observation related to its interaction with mitochondrial membranes.
Abou-Khalil, Wafa H   +2 more
core   +1 more source

Ticlopidine-related thrombotic thrombocytopenic purpura (Moschowitz syndrome)

open access: yes, 2000
Ticlopidine-related thrombotic thrombocytopenic purpura (Moschowitz ...
Lugano M   +11 more
core   +1 more source

Blood lipid profile in healthy subjects treated with ticlopidine

open access: yes, 1985
The study was carried out in order to evaluate if Ticlopidine induces lipid metabolism changes. Twenty seven healthy subjects were studied, 14 with placebo and 13 with Ticlopidine treatment (500 mg/day), for 30 days.
BALSANO F.   +5 more
core   +1 more source

Ticlopidine prevents the formation but delays the healing of ethanol-induced gastric lesions in the rat

open access: yes, 2007
The effects of acute or long-term oral ticlopidine administration in normal rat gastric mucosa or on gastric lesions induced by ethanol 50% (EtOH, 1ml/rat, os) were examined and compared with those of acetylsalicylic acid (ASA).
F. Pagani   +6 more
core   +1 more source

Anaemia and agranulocytosis associated with ticlopidine therapy

open access: yes, 1985
Although ticlopidine has proven anti-aggregant properties, complications due to side-effects, particularly to the haemopoietic system, have been noted since it was recently launched on the market.
AVERSA, Franco   +3 more
core  

Home - About - Disclaimer - Privacy